Mitochondrial diseases: genotype versus phenotype.

D. Wallace

DOI: https://doi.org/10.1016/0168-9525(93)90207-X

IF: 11.4

1993-04-01

Trends in Genetics

Abstract:

What problem does this paper attempt to address?

Nuclear Genes and Mitochondrial Genes Associated with Mitochondrial Diseases

Qingfeng Yan,Min‐Xin Guan

2008-01-01

Abstract:The study of mitochondria and diseases is a very hot field in biomedicine.We introduce here the basic knowledge of mitochondrial medicine and the hereditary character of mitochondrial diseases.In this review we highlight the most recent advances in the field,including the correlation of mitochondrial DNA (mtDNA) mutations and diseases,nuclear gene mutations and diseases.In particular,the molecular mechanisms of regulation of nuclear modifier genes on the phenotypic expression of mtDNA mutations are discussed in detail.
Mitochondrial functional defects and the disorders in the nervous system

MI Hui,LIN Bei,GUAN Min-Xin

2012-01-01

Abstract:Mitochondrial diseases have traditionally been ascribed to defects of the respiratory chain,which helped researchers explain their genetic and clinical complexity.However,other mitochondrial functions are greatly important for the nervous system,including protein importation,organellar dynamics,and cell death.Defects in genes controlling these functions are attracting increasing attention as causes not only of neurological and psychiatric diseases but also of age-related neurodegenerative disorders.After discussing some pathogenic conundrums regarding the neurological diseases of the respiratory chain defects,we review altered mitochondrial dynamics in the etiology of specific neurological diseases and in the physiopathology of more common neurodegenerative disorders.
Pathogenic Mutations of Nuclear Genes Associated with Mitochondrial Disorders.

Xiaoyu Zhu,Xuerui Peng,Min-Xin Guan,Qingfeng Yan

DOI: https://doi.org/10.1093/abbs/gmn021

2009-01-01

Abstract:Mitochondrial disorders are clinical phenotypes associated with mitochondrial dysfunction, which can be caused by mutations in mitochondrial DNA (mtDNA) or nuclear genes. In this review, we summarized the pathogenic mutations of nuclear genes associated with mitochondrial disorders. These nuclear genes encode, components of mitochondrial translational machinery and structural subunits and assembly factors of the oxidative phosphorylation, that complex. The molecular mechanisms, that nuclear modifier genes modulate the phenotypic expression of mtDNA mutations, are discussed in detail.
[Mitochondrial Genetics and Human Essential Hypertension].

Hong Chen,Min-xin Guan

DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2012.03.010

2012-01-01

Abstract:Mitochondrial DNA (mtDNA) exhibits matrilineal inherence. Familial mitochondrial diseases caused by mtDNA mutations are generally involved in organs featuring high energy consumption, which include heart, brain and skeletal muscle. Recently, it has been found that some essential hypertension patients featured classical maternal inheritance, which has confirmed and enriched mtDNA mutations as one of the molecular mechanisms underlying maternally inherited hypertension. Nevertheless, more general as well as radical questions are still to be answered. This article reviews recent advance in mitochondrial genome evolution, mtDNA genetics and the role of mtDNA mutations in maternally inherited hypertension.
Mouse Models of Mitochondrial Disease and Their Pathophysiology

FANG Fang,GUAN Min-Xin

DOI: https://doi.org/10.13376/j.cbls/2012.02.010

2012-01-01

Abstract:Mitochondrial disease is a kind of multi-system disease,resulting from energy shortage by ATP synthesis defect.As the development of mitochondrial disease mouse model during the past decade,nuclear DNA or(and) mitochondrial DNA mutations have been confirmed to be the main reasons to cause defects in mitochondrial oxidative phosphorylation for the diseases.In this review,we will focus on the characteristic of the mitochondrial disease mouse models and their pathophysiology.
Mitochondrion and Its Related Disorders: Making a Comeback

Xianning Zhang,Ming Qi

DOI: https://doi.org/10.1631/jzus.b0710621

2008-01-01

Journal of Zhejiang University SCIENCE B

Abstract:The great majority of genetic disorders are caused by defects in the nuclear genome. However, some significant diseases are the result of mitochondrial mutations. Because of the unique features of the mitochondria, these diseases display characteristic modes of inheritance and a large degree of phenotypic variability. Recent studies have suggested that mitochondrial dysfunction plays a central role in a wide range of age-related disorders and various forms of cancer.
A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation

Chao Chen,Ye Chen,Min-Xin Guan

DOI: https://doi.org/10.1007/s13238-015-0175-z

2015-06-18

Abstract:ABSTRACTMitochondrial genome is responsible for multiple human diseases in a maternal inherited pattern, yet phenotypes of patients in a same pedigree frequently vary largely. Genes involving in epigenetic modification, RNA processing, and other biological pathways, rather than “threshold effect” and environmental factors, provide more specific explanation to the aberrant phenotype. Thus, the double hit theory, mutations both in mitochondrial DNA and modifying genes aggravating the symptom, throws new light on mitochondrial dysfunction processes. In addition, mitochondrial retrograde signaling pathway that leads to reconfiguration of cell metabolism to adapt defects in mitochondria may as well play an active role. Here we review selected examples of modifier genes and mitochondrial retrograde signaling in mitochondrial disorders, which refine our understanding and will guide the rational design of clinical therapies.

cell biology
Genetics of mitochondrial diseases: Current approaches for the molecular diagnosis

Lea D Schlieben,Holger Prokisch

DOI: https://doi.org/10.1016/B978-0-12-821751-1.00011-7

Abstract:Mitochondrial diseases are a genetically and phenotypically variable set of monogenic disorders. The main characteristic of mitochondrial diseases is a defective oxidative phosphorylation. Both nuclear and mitochondrial DNA encode the approximately 1500 mitochondrial proteins. Since identification of the first mitochondrial disease gene in 1988 a total of 425 genes have been associated with mitochondrial diseases. Mitochondrial dysfunctions can be caused both by pathogenic variants in the mitochondrial DNA or the nuclear DNA. Hence, besides maternal inheritance, mitochondrial diseases can follow all modes of Mendelian inheritance. The maternal inheritance and tissue specificity distinguish molecular diagnostics of mitochondrial disorders from other rare disorders. With the advances made in the next-generation sequencing technology, whole exome sequencing and even whole-genome sequencing are now the established methods of choice for molecular diagnostics of mitochondrial diseases. They reach a diagnostic rate of more than 50% in clinically suspected mitochondrial disease patients. Moreover, next-generation sequencing is delivering a constantly growing number of novel mitochondrial disease genes. This chapter reviews mitochondrial and nuclear causes of mitochondrial diseases, molecular diagnostic methodologies, and their current challenges and perspectives.
Diagnostic challenges of mitochondrial DNA disorders

Lee-Jun C Wong

DOI: https://doi.org/10.1016/j.mito.2006.11.025

IF: 4.534

Mitochondrion

Abstract:Although mitochondrial disorders are increasingly being recognized, confirming a specific diagnosis remains a great challenge due to the genetic and clinical heterogeneity of the disease. The heteroplasmic nature of most pathogenic mitochondrial DNA mutations and the uncertainties of the clinical significance of novel mutations pose additional complications in making a diagnosis. Suspicion of mitochondrial disease among patients with multiple, seemingly unrelated neuromuscular and multi-system disorders should ideally be confirmed by the finding of deleterious mutations in genes involving mitochondrial biogenesis and functions. The genetics are complex, as the primary mutation can be either in the nuclear or the mitochondrial DNA (mtDNA). MtDNA mutations are often maternally inherited, but can also be sporadic or secondary to mutations in nuclear-encoded mitochondrial-targeted genes. Several well-defined clinical syndromes associated with specific mutations have been described, yet the genotype-phenotype correlation is often unclear and most patients do not fit within any defined syndrome and even within a family the expressivity of the disease can be extremely variable. This article describes examples representing diagnostic challenges of mitochondrial diseases that include the limitations of the mutation detection method, the occurrence of mitochondrial disease in families with another known neuromuscular disorder, atypical clinical presentation, the lack of correlation between the degree of mutant heteroplasmy and the severity of the disease, variable penetrance, and nuclear gene defects causing mtDNA depletion.
Mitochondrial Russian doll genes may explain some discrepancies in links between mtDNA mutations and mitochondrial diseases

Sophie Breton

DOI: https://doi.org/10.1002/bies.202100104

2021-05-19

BioEssays

Abstract:Mitochondrial DNA mutations are responsible for a variety of human disorders due to defects in oxidative energy metabolism, and they are also involved in aging, aging-related diseases and multiple types of cancer.[<a class="bibLink tab-link" href="#bies202100104-bib-0001">1</a>, <a class="bibLink tab-link" href="#bies202100104-bib-0002">2</a>] The variety of pathologies caused by mtDNA mutations is remarkable, but the relationship between genotype and disease phenotype is not always straightforward, most probably due to the complexity of mitochondrial biology. Indeed, because mtDNA is present in multiple copies within each cell, when mutated and wild-type mtDNA molecules coexist in a given tissue (heteroplasmic condition), the mutated mtDNA has to reach a certain copy number to cause mitochondrial dysfunction (threshold effect). The threshold effect varies among mutation types (e.g., in protein-coding genes or mt-tRNAs) and also among tissues because of their different dependence on oxidative metabolism. The heterogeneity of phenotypes can be explained by differences in mutational load reaching the pathogenic threshold in some tissues but not in others.[<a class="bibLink tab-link" href="#bies202100104-bib-0001">1</a>, <a class="bibLink tab-link" href="#bies202100104-bib-0002">2</a>]

biochemistry & molecular biology,biology
Mitochondrial Diseases: Hope for the Future

Oliver M. Russell,Gráinne S. Gorman,Robert N. Lightowlers,Doug M. Turnbull

DOI: https://doi.org/10.1016/j.cell.2020.02.051

IF: 64.5

2020-04-01

Cell

Abstract:Mitochondrial diseases are clinically heterogeneous disorders caused by a wide spectrum of mutations in genes encoded by either the nuclear or the mitochondrial genome. Treatments for mitochondrial diseases are currently focused on symptomatic management rather than improving the biochemical defect caused by a particular mutation. This review focuses on the latest advances in the development of treatments for mitochondrial disease, both small molecules and gene therapies, as well as methods to prevent transmission of mitochondrial disease through the germline.

cell biology,biochemistry & molecular biology
Digenic Inheritance in Rare Disorders and Mitochondrial Disease—Crossing the Frontier to a More Comprehensive Understanding of Etiology

Christiane M. Neuhofer,Holger Prokisch

DOI: https://doi.org/10.3390/ijms25094602

IF: 5.6

2024-04-24

International Journal of Molecular Sciences

Abstract:Our understanding of rare disease genetics has been shaped by a monogenic disease model. While the traditional monogenic disease model has been successful in identifying numerous disease-associated genes and significantly enlarged our knowledge in the field of human genetics, it has limitations in explaining phenomena like phenotypic variability and reduced penetrance. Widening the perspective beyond Mendelian inheritance has the potential to enable a better understanding of disease complexity in rare disorders. Digenic inheritance is the simplest instance of a non-Mendelian disorder, characterized by the functional interplay of variants in two disease-contributing genes. Known digenic disease causes show a range of pathomechanisms underlying digenic interplay, including direct and indirect gene product interactions as well as epigenetic modifications. This review aims to systematically explore the background of digenic inheritance in rare disorders, the approaches and challenges when investigating digenic inheritance, and the current evidence for digenic inheritance in mitochondrial disorders.

biochemistry & molecular biology,chemistry, multidisciplinary
Skeletal Phenotypes Due to Abnormalities in Mitochondrial Protein Homeostasis and Import

Tian Zhao,Caitlin Goedhart,Gerald Pfeffer,Steven C Greenway,Matthew Lines,Aneal Khan,A Micheil Innes,Timothy E Shutt

DOI: https://doi.org/10.3390/ijms21218327

2020-11-06

Abstract:Mitochondrial disease represents a collection of rare genetic disorders caused by mitochondrial dysfunction. These disorders can be quite complex and heterogeneous, and it is recognized that mitochondrial disease can affect any tissue at any age. The reasons for this variability are not well understood. In this review, we develop and expand a subset of mitochondrial diseases including predominantly skeletal phenotypes. Understanding how impairment ofdiverse mitochondrial functions leads to a skeletal phenotype will help diagnose and treat patients with mitochondrial disease and provide additional insight into the growing list of human pathologies associated with mitochondrial dysfunction. The underlying disease genes encode factors involved in various aspects of mitochondrial protein homeostasis, including proteases and chaperones, mitochondrial protein import machinery, mediators of inner mitochondrial membrane lipid homeostasis, and aminoacylation of mitochondrial tRNAs required for translation. We further discuss a complex of frequently associated phenotypes (short stature, cataracts, and cardiomyopathy) potentially explained by alterations to steroidogenesis, a process regulated by mitochondria. Together, these observations provide novel insight into the consequences of impaired mitochondrial protein homeostasis.
Genetic basis of mitochondrial diseases

Mirjana Gusic,Holger Prokisch

DOI: https://doi.org/10.1002/1873-3468.14068

2021-03-21

FEBS Letters

Abstract:Mitochondrial disorders are monogenic disorders characterized by a defect in oxidative phosphorylation and caused by pathogenic variants in one of over 340 different genes. The implementation of whole exome sequencing has led to a revolution in their diagnosis, duplicated the number of associated disease genes, and significantly increased the diagnosed fraction. However, the genetic etiology of a substantial fraction of patients exhibiting mitochondrial disorders remains unknown, highlighting limitations in variant detection and interpretation, which calls for improved computational and DNA sequencing methods, as well as the addition of OMICS tools. More intriguingly, this also suggests that some pathogenic variants lie outside of the protein‐coding genes and that the mechanisms beyond the Mendelian inheritance and the mtDNA are of relevance. This review covers the current status of the genetic basis of mitochondrial diseases, discusses current challenges and perspectives, and explores the contribution of factors beyond the protein‐coding regions and monogenic inheritance in the expansion of the genetic spectrum of disease.

cell biology,biochemistry & molecular biology,biophysics
Mitochondrial molecular genetics and human disease

Eric A Shoubridge,Antoni Barrientos

DOI: https://doi.org/10.1093/hmg/ddae049

IF: 5.1214

2024-05-25

Human Molecular Genetics

Abstract:The human mitochondrial genome (mtDNA) was sequenced in 1981 long before advances that made sequencing of the entire human genome possible, the first draft of which was released about 20 years later. Although mtDNA makes up only a small percentage of the total cellular DNA, it has assumed outsized importance because of its implication in human diseases, as well as its role in priming the innate immune response and in inflammation. Human mtDNA codes for only 37 genes that express a handful of polypeptides, all essential subunits of the oxidative phosphorylation complexes, and the rRNAs and tRNAs necessary for their synthesis on dedicated mitochondrial ribosomes. MtDNA relies on the expression of hundreds of nucleus-encoded genes for its maintenance, replication, repair, transcription, and translation. Consequently, the expression of the nuclear and mitochondrial genomes requires exquisite coordination. Hundreds of mutations in mtDNA and the nuclear genes necessary for its expression have now been identified in a strikingly diverse array of human disease phenotypes. The reviews gathered in this special issue address recent developments in our understanding of the molecular genetics of mtDNA expression, mitochondrial disease pathogenesis, the role of mtDNA in innate immunity, and the emerging tools for mtDNA editing.

genetics & heredity,biochemistry & molecular biology
Neurological Mitochondrial Diseases

H. Lee,Y. Lee

DOI: https://doi.org/10.3760/cma.j.issn.1006-7876.2019.04.013

2019-01-01

Abstract:Mitochondrial disease (MD) is a group of metabolic disorders,caused by mitochondrial DNA or nuclear DNA mutations.With the development of research in mitochondrial medicine,the phenotypic spectrum of MD has expanded significantly.The common phenotypes in Chinese population included mitochondrial encephalopathy with lactic acidosis and stroke like episodes,Leigh syndrome,Leber hereditary optic neuropathy and chronic progressive external ophthalmoplegia.The rare phenotype included myoclonic epilepsy with ragged-red fibers,Kearns-Sayre syndrome,sensory ataxic neuropathy,mitochondrial neurogastrointestinal encephalomyopathy,Alpers disease,limb girdle mitochondrial myopathy,neuropathy with ataxia and retinitis pigmentosa.However,considerable clinical variability exists and some individuals do not fit into the known disease category.The revolution in genetic technologies has dramatically improved the diagnosis strategy of MD.In this article the pathology,clinical symptoms,laboratory findings and therapy in MD are sumarrized so as to provide guidance for clinical practice.
Low "penetrance" of Phylogenetic Knowledge in Mitochondrial Disease Studies.

HJ Bandelt,A Achilli,QP Kong,A Salas,S Lutz-Bonengel,C Sun,YP Zhang,A Torroni,YG Yao

DOI: https://doi.org/10.1016/j.bbrc.2005.04.055

IF: 3.1

2005-01-01

Biochemical and Biophysical Research Communications

Abstract:An up-to-date view of the worldwide mitochondrial DNA (mtDNA) phylogeny together with an evaluation of the conservation of each site is a reliable tool for detecting errors in mtDNA studies and assessing the functional importance of alleged pathogenic mutations. However, most of the published studies on mitochondrial diseases make very little use of the phylogenetic knowledge that is currently available. This drawback has two inadvertent consequences: first, there is no sufficient a posteriori quality assessment of complete mtDNA sequencing efforts; and second, no feedback is provided for the general mtDNA database when apparently new mtDNA lineages are discovered. We demonstrate, by way of example, these issues by reanalysing three mtDNA sequencing attempts, two from Europe and another one from East Asia. To further validate our phylogenetic deductions, we completely sequenced two mtDNAs from healthy subjects that nearly match the mtDNAs of two patients, whose sequences gave problematic results.
Mitochondrial diseases in adults

C. La Morgia,A. Maresca,L. Caporali,M. L. Valentino,V. Carelli

DOI: https://doi.org/10.1111/joim.13064

2020-05-28

Journal of Internal Medicine

Abstract:Mitochondrial medicine is a field that expanded exponentially in the last 30 years. Individually rare, mitochondrial diseases as a whole are probably the most frequent genetic disorder in adults. The complexity of their genotype–phenotype correlation, in terms of penetrance and clinical expressivity, natural history and diagnostic algorithm derives from the dual genetic determination. In fact, in addition to the about 1.500 genes encoding mitochondrial proteins that reside in the nuclear genome (nDNA), we have the 13 proteins encoded by the mitochondrial genome (mtDNA), for which 22 specific tRNAs and 2 rRNAs are also needed. Thus, besides Mendelian genetics, we need to consider all peculiarities of how mtDNA is inherited, maintained and expressed to fully understand the pathogenic mechanisms of these disorders. Yet, from the initial restriction to the narrow field of oxidative phosphorylation dysfunction, the landscape of mitochondrial functions impinging on cellular homeostasis, driving life and death, is impressively enlarged. Finally, from the clinical standpoint, starting from the neuromuscular field, where brain and skeletal muscle were the primary targets of mitochondrial dysfunction as energy‐dependent tissues, after three decades virtually any subspecialty of medicine is now involved. We will summarize the key clinical pictures and pathogenic mechanisms of mitochondrial diseases in adults.

medicine, general & internal
Evaluation of the YSI 2300 glucose analyzer: algorithm-corrected results are accurate and specific.

J. R. Astles,F. Sedor,J. Toffaletti

DOI: https://doi.org/10.1016/0009-9120(95)02010-1

IF: 3.625

1996-02-01

Clinical Biochemistry

Abstract:
A Drosophila model of mitochondrial disease phenotypic heterogeneity

Lucy Granat,Debbra Y. Knorr,Daniel C. Ranson,Ram Prosad Chakrabarty,Navdeep S. Chandel,Joseph M. Bateman

DOI: https://doi.org/10.1242/bio.060278

2024-02-15

Biology Open

Abstract:ABSTRACT Mutations in genes that affect mitochondrial function cause primary mitochondrial diseases. Mitochondrial diseases are highly heterogeneous and even patients with the same mitochondrial disease can exhibit broad phenotypic heterogeneity, which is poorly understood. Mutations in subunits of mitochondrial respiratory complex I cause complex I deficiency, which can result in severe neurological symptoms and death in infancy. However, some complex I deficiency patients present with much milder symptoms. The most common nuclear gene mutated in complex I deficiency is the highly conserved core subunit NDUFS1. To model the phenotypic heterogeneity in complex I deficiency, we used RNAi lines targeting the Drosophila NDUFS1 homolog ND-75 with different efficiencies. Strong knockdown of ND-75 in Drosophila neurons resulted in severe behavioural phenotypes, reduced lifespan, altered mitochondrial morphology, reduced endoplasmic reticulum (ER)-mitochondria contacts and activation of the unfolded protein response (UPR). By contrast, weak ND-75 knockdown caused much milder behavioural phenotypes and changes in mitochondrial morphology. Moreover, weak ND-75 did not alter ER-mitochondria contacts or activate the UPR. Weak and strong ND-75 knockdown resulted in overlapping but distinct transcriptional responses in the brain, with weak knockdown specifically affecting proteosome activity and immune response genes. Metabolism was also differentially affected by weak and strong ND-75 knockdown including gamma-aminobutyric acid (GABA) levels, which may contribute to neuronal dysfunction in ND-75 knockdown flies. Several metabolic processes were only affected by strong ND-75 knockdown including the pentose phosphate pathway and the metabolite 2-hydroxyglutarate (2-HG), suggesting 2-HG as a candidate biomarker of severe neurological mitochondrial disease. Thus, our Drosophila model provides the means to dissect the mechanisms underlying phenotypic heterogeneity in mitochondrial disease.

biology

Mitochondrial diseases: genotype versus phenotype.

Nuclear Genes and Mitochondrial Genes Associated with Mitochondrial Diseases

Mitochondrial functional defects and the disorders in the nervous system

Pathogenic Mutations of Nuclear Genes Associated with Mitochondrial Disorders.

[Mitochondrial Genetics and Human Essential Hypertension].

Mouse Models of Mitochondrial Disease and Their Pathophysiology

Mitochondrion and Its Related Disorders: Making a Comeback

A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation

Genetics of mitochondrial diseases: Current approaches for the molecular diagnosis

Diagnostic challenges of mitochondrial DNA disorders

Mitochondrial Russian doll genes may explain some discrepancies in links between mtDNA mutations and mitochondrial diseases

Mitochondrial Diseases: Hope for the Future

Digenic Inheritance in Rare Disorders and Mitochondrial Disease—Crossing the Frontier to a More Comprehensive Understanding of Etiology

Skeletal Phenotypes Due to Abnormalities in Mitochondrial Protein Homeostasis and Import

Genetic basis of mitochondrial diseases

Mitochondrial molecular genetics and human disease

Neurological Mitochondrial Diseases

Low "penetrance" of Phylogenetic Knowledge in Mitochondrial Disease Studies.

Mitochondrial diseases in adults

Evaluation of the YSI 2300 glucose analyzer: algorithm-corrected results are accurate and specific.

A Drosophila model of mitochondrial disease phenotypic heterogeneity